The Oliver Fund Scholars Award

2013-2014 Applications Due Monday November 11, 2013

 The Oliver Fund was created to support and enhance Tulane’s faculty and intellectual capital as among the institution’s most valuable resources. The fund is intended to represent an enabling resource to stimulate outstanding faculty research initiatives, to sustain such projects and to increase their competitiveness for national research support. The Oliver Fund supports a competitive, merit-based faculty award process, with focus on faculty-driven, interdisciplinary research initiatives in the sciences and engineering broadly defined. Competitions are held annually, each focused on a particular area of research strength at Tulane. Award recipients are named as Oliver Fund Scholars.

The 2013-2014 competition will focus on outstanding research inHealth Disparities, including social, behavioral or biomedical influences. 

A prize of $40,000 will be awarded to support research initiatives of the Oliver Fund Scholar. Proposals will be reviewed by a committee of senior Tulane faculty and external experts, according to the following criteria:

♦ The scientific merit of the project.
♦ Evidence of accomplishment of the applicant.
♦ The potential to elevate the national visibility and reputation of Tulane University faculty for excellence in research accomplishment.
♦ The potential for future support from competitive national funding agencies. It is expected that a grant application to a federal agency (e.g., NIH, NSF) will be submitted within one year of the award.
♦ The potential to strengthen Tulane’s educational offerings through increased opportunity for student participation in research.

       Proposals should be submitted to the Vice President for Research ( by
                MONDAY, NOVEMBER 11 in a format consistent with these guidelines (PDF).


Recent Oliver Fund Scholars


Fall 2012

Dr. William C. Wimley022113_wimley_gcr_330
Professor, Department of Biochemistry

Professor Wimley will study antimicrobial peptides as a possible novel treatment alternative to antibiotics for the global epidemic of drug-resistant bacterial infections. A major advantage of these molecules over antibiotics is that bacteria do not develop resistance to peptides. His laboratory will develop methods for screening large numbers of peptides to identify those with antimicrobial properties, and determine which peptides are most effective, have few side effects, and are simple and inexpensive to manufacture.


Fall 2011

mooreDr. Michael J. Moore
Paul H. and Donna D. Flower Early Career Professor in Engineering
Department of Biomedical Engineering

 Dr. Moore's laboratory will begin to focus on uses for induced pluripotent stem cells (adult stem cells that have been reprogrammed to behave more like embryonic stem cells). The Neural Micro-Engineering Laboratory is developing a set of new nanomaterials designed to evaluate the ability of these cells to grow into functional nervous tissue, and ultimately be used to treat central nervous system disorders like stroke and spinal cord injury.


Fall 2010

Torbjorn Tornqvist


Dr. Torbjörn Törnqvist 
Professor, School of Science and Engineering
Department of Earth and Environmental Sciences

Professor Törnqvist will study sea-level changes due to melting ice in the period called the early Holocene, 12,000 to 6,000 years ago. The Mississippi delta region offers a uniquely favorable setting for collecting sediment cores that will provide new, more precise data about early Holocene ice sheet/sea level interactions. In addition to drilling new cores, Törnqvist will improve the record of sea-level changes using cores he has already collected.


Spring 2010



Dr. Vivian Fonseca
School of Medicine
Professor of Medicine; Chief of Endocrinology
Tullis-Tulane Alumni Chair in Diabetes

Dr. Fonseca, who is also Vice President of Science and Medicine for the American Diabetes Association, will further his research in the management and treatment of diabetes. Dr. Fonseca's team is testing the efficacy of adult stem cells, cultured from the fat tissue of non-diabetic subjects, in controlling inflammation and tissue damage caused by diabetes.



Fall 2009Kobori2

Dr. Hiroyuki Kobori 
School of Medicine
Associate Professor of Physiology
Tulane Hypertension and Renal Center of Excellence

Dr. Kobori's research aims to develop a more thorough understanding the renin-angiotensin system in the kidney and how it relates to the development of hypertension and kidney disease. In addition, Dr. Kobori hopes to establish guidelines for the development and selection of treatments for hypertension, along with a monitoring system that will follow and evaluate patients during treatment.   


1440 Canal Street Suite, 2400, TW-5, New Orleans, LA 70112 504-988-3291